Mucocort’s innovation strategy highlighted in Scientia Global
Mucocort, a UBI-supported company, has been featured in a newly published article in Scientia Global. The article highlights the company’s Close-to-Market innovation strategy and how existing compounds can be transformed into new therapies through its 4R framework: Repurposing, Reformulation, Repositioning and Re-patenting.